Form 4 for BIIB Biogen
Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-04 · accession 0001127602-23-012691 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-06 | 2023-04-04 | BIIB | Singhal Priya | Head of Development | S - Sale | $277.11 | -91 | 2,843 | -3% | -$25.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-04 | S | D | 91 | $277.11 | 2,843.09 | D | — | — | (F1) Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan. |